Publication | Closed Access
A Phase II Study of 5-AZA-2'Deoxycytidine (Decitabine) in Hormone Independent Metastatic (D2) Prostate Cancer
136
Citations
12
References
1998
Year
We conclude that decitabine is a well tolerated regimen with modest clinical activity against hormone-independent prostate cancer. Further investigations in patients of African-American origin may be warranted.
| Year | Citations | |
|---|---|---|
Page 1
Page 1